How to capture the benefits of traditional fasting in contemporary life.
What the evidence says
- In rodents, restricting access to high-fat food to 8–12 hours a day ”does not reduce overall caloric intake (compared to animals fed ad libitum), but improves circadian rhythms and helps prevent or reverse metabolic diseases” — the species is `cfs01`’s own qualifier and must travel with the claim (corrected 2026-09-10, following `cfs01`, from ”does not reduce overall caloric intake yet still prevents metabolic disease”: the paper’s animals are on high-fat food, and it says helps prevent or reverse)[1]
- Human TRF, and the sample is the point: eight overweight participants eating within a 10-11 hour window lost up to 4% of body weight in 16 weeks, with caloric intake falling by up to 20% (”some of this reduction came from reduction in late night alcohol and snacks”), improved sleep, and the weight loss ”retained … for up to 1 year” (corrected 2026-09-10, following `cfs01`, from ”falling spontaneously” and ”results sustained at 1 year”, the summary file’s wording)[1]
- Eating patterns that reduce/eliminate nighttime eating and prolong nightly fasting may produce sustained health improvements[2]
- In rodents, intermittent fasting (<24-hour cycles) enhances cognitive performance and improves insulin sensitivity — `cfs01`'s sentence is "in rodents IF enhances cognitive performance … and also improves insulin sensitivity", and both halves carry that qualifier[1]
- ”The timing of food intake with respect to the 24-hour light–dark cycle likely has an important influence on food intake, as well as on energy efficiency and weight control” (corrected 2026-09-10 from ”Nighttime eating reduction may be as important as total caloric intake”: the paper makes no such comparison, and as important as does not occur in it)[2]
- `cft03` reviews IF as a candidate population-level intervention, and its own numbers are modest: across nine modified-fasting trials running 2 to 6 months, seven reported statistically significant weight loss ranging from 3.2% to 8.0%, and the review’s reading of the comparison literature is that the overall metabolic benefits of fasting regimens are not superior to those of continuous energy restriction[2]
- On markers, the nine modified-fasting trials (the regimen behind the 5:2 diet) were mixed: ”Three of six studies found significant decreases in fasting insulin, and one found reductions in fasting glucose. Three of eight studies found significant improvements in circulating LDL cholesterol or TGs. Three of six studies found significant improvements in inflammatory markers” (corrected 2026-09-10 from ”Where it does report improvement, it is in markers rather than in weight: 5:2 regimens improved fasting insulin, fasting glucose, LDL, triglycerides and inflammatory markers across the 16 human trials reviewed”. The review does report weight loss: ”Among the 16 intervention trials included in this review, 11 reported statistically significant weight loss”, and the bullet above gives 7 of the 9 modified-fasting trials. The marker results come from subsets of those nine, not from all sixteen)[2]